Patents by Inventor Yuanyuan TAO

Yuanyuan TAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OPHTHALMIC CONDITIONS
    Publication number: 20230398073
    Abstract: The invention provides emulsion compositions comprising at least one cannabinoid compound, and methods for making the same. The emulsion compositions are stable, well tolerated and are capable of delivering therapeutically effective amounts of cannabiniods to target sites, including sites on the surface of and/or within an eye. Also provided are methods of using the compositions to provide ocular neuroprotection and/or to treat ophthalmic conditions such as glaucoma.
    Type: Application
    Filed: August 22, 2023
    Publication date: December 14, 2023
    Applicant: Rhodes Technologies
    Inventors: Ping CHANG, Zhenze Hu, Yuanyuan TAO
  • Pharmaceutical compositions for the treatment of ophthalmic conditions
    Patent number: 11786463
    Abstract: The invention provides emulsion compositions comprising at least one cannabinoid compound, and methods for making the same. The emulsion compositions are stable, well tolerated and are capable of delivering therapeutically effective amounts of cannabiniods to target sites, including sites on the surface of and/or within an eye. Also provided are methods of using the compositions to provide ocular neuroprotection and/or to treat ophthalmic conditions such as glaucoma.
    Type: Grant
    Filed: August 10, 2018
    Date of Patent: October 17, 2023
    Assignee: Rhodes Technologies
    Inventors: Ping Chang, Zhenze Hu, Yuanyuan Tao
  • PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OPHTHALMIC CONDITIONS
    Publication number: 20210299046
    Abstract: The invention provides emulsion compositions comprising at least one cannabinoid compound, and methods for making the same. The emulsion compositions are stable, well tolerated and are capable of delivering therapeutically effective amounts of cannabiniods to target sites, including sites on the surface of and/or within an eye. Also provided are methods of using the compositions to provide ocular neuroprotection and/or to treat ophthalmic conditions such as glaucoma.
    Type: Application
    Filed: August 10, 2018
    Publication date: September 30, 2021
    Applicant: Rhodes Technologies
    Inventors: Ping CHANG, Zhenze HU, Yuanyuan TAO